PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.39%
Negative revenue growth while 8198.HK stands at 339.07%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.05%
Negative gross profit growth while 8198.HK is at 335.66%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-49.95%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-11.57%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-10.80%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-10.80%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.83%
Share reduction while 8198.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.83%
Reduced diluted shares while 8198.HK is at 0.40%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-125.46%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-125.55%
Negative FCF growth while 8198.HK is at 28.31%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-64.23%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-63.34%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-63.63%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-231.27%
Negative 10Y OCF/share CAGR while 8198.HK stands at 77.42%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-246.17%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
49.50%
Positive 3Y OCF/share CAGR while 8198.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-77.53%
Negative 10Y net income/share CAGR while 8198.HK is at 91.66%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-41.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-51.85%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
2.52%
Positive 5Y equity/share CAGR while 8198.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-1.93%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-51.20%
Negative 5Y dividend/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-15.61%
Negative near-term dividend growth while 8198.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
2.61%
AR growth of 2.61% while 8198.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-13.49%
Inventory is declining while 8198.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-11.95%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.49%
BV/share growth of 1.49% while 8198.HK is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-60.19%
We’re deleveraging while 8198.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while 8198.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-18.87%
We cut SG&A while 8198.HK invests at 79.79%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.